PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
03-Dec-2021 The Use of Drug Master Files & Quality Agreements: Understanding and Meeting your Regulatory and Processing Responsibilities: 6-Hour Virtual Seminar , 16th December 2021 - ResearchAndMarkets.com Businesswire
03-Dec-2021 European Pharmaceutical Contract Manufacturing Market Growth Trends 2021-2026: Increasing Outsourcing Volume by Pharmaceutical Companies - ResearchAndMarkets.com Businesswire
03-Dec-2021 Global Cellulose Ether & Derivatives Market Forecast to 2026: Carboxymethyl Cellulose Product Type Dominated the Overall Market - ResearchAndMarkets.com Businesswire
03-Dec-2021 United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2022 Businesswire
03-Dec-2021 Global Preimplantation Genetic Testing Market to Reach $2,725.7 Million by 2031 - ResearchAndMarkets.com Businesswire
03-Dec-2021 Global Medical Seals Market Share, Trends and Forecasts to 2026: Market Recovery with CAGR of 6.3% Forecast, to Reach US$ 1.9 Billion in 2026 - ResearchAndMarkets.com Businesswire
03-Dec-2021 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
03-Dec-2021 Celyad Oncology Announces $32.5 Million Private Placement With Fortress Investment Group Businesswire
03-Dec-2021 Phase III Investigational Trial of NUBEQA® (darolutamide) in Combination with Docetaxel and Androgen Deprivation Therapy (ADT) Meets Primary Endpoint of Significantly Increasing Overall Survival (OS) in Patients with mHSPC Businesswire
03-Dec-2021 BeiGene and EUSA Pharma Announce NMPA Approval of SYLVANT® (Siltuximab for Injection) in China for Idiopathic Multicentric Castleman Disease Businesswire
03-Dec-2021 BeiGene Announces Inclusion in the China National Reimbursement Drug List (NRDL) of Tislelizumab in Three New Indications, BRUKINSA® (Zanubrutinib) in One New Indication, and the First Listing for Pamiparib Businesswire
03-Dec-2021 BeiGene and EUSA Pharma Announce NMPA Approval of SYLVANT® (Siltuximab for Injection) in China for Idiopathic Multicentric Castleman Disease Businesswire
02-Dec-2021 Boston Properties Executes Three Leases Totaling 166,000 SF at 880 Winter Street in Waltham, MA Businesswire
02-Dec-2021 Aptar in Top 10 of America’s Most Responsible Companies 2022 by Newsweek Businesswire
02-Dec-2021 Scipher Medicine Appoints Dr. Michael Elliott to its Science Advisory Board Businesswire
02-Dec-2021 Real Chemistry Founder and Chief Executive Officer Jim Weiss to Become Chairman and Shankar Narayanan to Become Chief Executive Officer Businesswire
02-Dec-2021 Vifor Pharma comments on market speculations Businesswire
02-Dec-2021 Immuta Joins AWS ISV Accelerate Program Businesswire
02-Dec-2021 Tevogen Bio Announces its Investigational SARS-CoV-2 Specific T cell Therapy, TVGN-489, Is Not Affected by Omicron Variant Following Research Team Review of all Reported Mutations Businesswire
02-Dec-2021 Global Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Clinical Trials Market Report, H2 2021 Review - ResearchAndMarkets.com Businesswire